Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality
Conclusions: In absolute terms, the risk reductions mean 19 fewer CHD deaths and 7 fewer stroke deaths per 1,000 women using any HT for at least 10 years.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Estradiol | Health | Heart | Heart Disease | Hormonal Therapy | Hormones | Men | Menopause | OBGYN | Stroke | Study | Women